期刊文献+

纤维蛋白原Bβ-455G/A、-854G/A基因多态性与其含量及分子活性的相关性研究 被引量:1

The Correlation Study of β-Fibrinogen Gene-455G/A、-854G/A Polymorphisms,Fibrinogen Concentration and Molecular Reactivity
下载PDF
导出
摘要 目的探讨血浆纤维蛋白原(Fbg)Bβ-455G/A、-854G/A基因型的分布特征及其基因多态性联合多种生理和环境因素对Fbg浓度和分子活性的影响。方法采用整体抽样的方法选取开滦集团职工1555人,样本均清晨空腹抽取静脉血测定血糖等12项生化指标;应用聚合酶链反应-限制性酶切法进行两位点的基因多态性分析;采用微机辅助血浆Fbg功能自动监测系统测定血浆Fbg浓度和Fbg单体聚合反应速率(FMPV)、最大光密度(Amax)、FMPV/Amax等反映Fbg分子聚合功能参数;并进行体检和问卷调查。结果Bβ-455等位基因G、A频率分布为0.798、0.202,Bβ-854等位基因G、A频率为0.899、0.101。两位点基因连锁不平衡分析为随机分布,两位点等位基因及基因型频率分布与性别无关(P>0.05);而高血压病组Bβ-455等位基因G、野生基因型频率均高于无高血压病组(P<0.05);Bβ-455各基因型组间Fbg浓度及分子活性指标均无差异性(P>0.05),Bβ-854GA+AA组Fbg浓度、FMPV/Amax、FMPV及Amax均明显高于GG组(P<0.01)。结论Bβ-455等位基因G和GG基因型与高血压病有关,但对Fbg浓度和分子活性无明显影响;Bβ-854的变异基因型可以明显影响血浆Fbg浓度和分子聚集活性,但可以通过改变某些生理和环境因素增强或减弱其影响的程度。 Objective To investigate the genotype distribution of β-Fbg gene-455G/A,-854G/A, and gene Bβ-455G/A,-854G/A polymorphisms combined many physiological and environmental factors electing on Fbg concentration and molecular reactivity. Methods 1555 subjects from Tangshan coalminewere enrolled with study method of cluster sampling. The Bβ-455G/A,-854G/A polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP). Fbg concentration,fibin monome polymerized velocity ( FMPV), absorbance maximum ( Amax), FMPV/Amax and twelve biochemistry factors including glucose were measured. Face to face interviews were conducted to fill in questionnaires by trained interviewers. Results The frequencies of the G-455, A-455, G-854, A-854 allelewere 0. 798,0. 202, 0. 899,0. 101, respectively. The relationship between Bβ-455G/A and Bβ-854G/A was a random distribution. No different prevalence rates of Bβ-455G/A and -854G/A were found on gender(P 〉0.05) ,but the distribution of G455 allele and GG genotype in the hypertension were higher than without the hypertension ( P 〈 0.05 ). No difference of Fbg concentration and molecular reactivity in Bβ- 455 G/A genotypes was found ( P 〉 0.05 ), The level of Fbg, FMPV/Amax, FMPV and Amax in GA and AA combined genotyp was significantly higher than that in GG genotype of Bβ-854 gene (P 〈 0.01 ). Conclusion G-455 allele andGG genotype of Bβ-455 have related in hypertension, but there is no association between Bβ-455 and Fbg concentration, molecular reactivity; Bβ- 854 genotypes have impact on Fbg concentration and molecular reactivity, further more, physiological and environmental factors might have coordinating functions.
出处 《血栓与止血学》 2009年第3期114-117,121,共5页 Chinese Journal of Thrombosis and Hemostasis
关键词 纤维蛋白原 Bβ-455G/A Bβ-854G/A 分子聚合功能 Fibrinogen Bβ-455G/A Bβ-854G/A Molecular reactivity
  • 相关文献

参考文献7

二级参考文献46

  • 1吴峰,马西,车金.纤维蛋白单体聚合反应的光学检测法[J].中华血液学杂志,1994,15(1):42-43. 被引量:24
  • 2符民桂,马西,纪卫东,卢阳.血浆纤维蛋白原单体聚合功能测定及应用[J].中华血液学杂志,1994,15(9):489-490. 被引量:27
  • 3马西.缺血性心脑血管病的纤维蛋白原分子反应性的观察[J].中华血液学杂志,1996,17(3):135-137. 被引量:46
  • 4[1]Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:1102-8.
  • 5[2]Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
  • 6[3]Thomas A, Lamlum H, Humphries S, et al. Green, linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HA EⅢ), C/T148 (Hind Ⅲ/AluⅠ), T/G+1689 (AvaⅢ), and BclⅠ (β-Fibrinogen) and TaqⅠ (α-Fibrinogen), and their detection by PCR. Hum Mutat 1994;3:79-81.
  • 7[4]van der Bom JG, de Maat MPM, Bots ML, et al. Elevated plasma fibrinogen. Cause or consequence of cardiovascular disease? Arterioscler Thromb Vasc Biol 1998;18:621-5.
  • 8[5]Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, et al. A common mutation (G-455→A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen,but not of ischemic heart disease. A study of 9127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997;99:3034-9.
  • 9[6]Connor JM, Fowkes FGR, Wood J, et al. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992;29:480-2.
  • 10[7]Carter AM, Mansfield MW, Stickland MH, et al. βfibrinogen gene -455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM. Diabetes Care 1996;19:1265-8.

共引文献68

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部